Free Trial

Cibus Q4 2022 Earnings Report

Cibus logo
$2.48 +0.01 (+0.40%)
As of 01/17/2025 04:00 PM Eastern

Cibus EPS Results

Actual EPS
-$3.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cibus Revenue Results

Actual Revenue
$0.04 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cibus Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Cibus Earnings Headlines

Missed Tesla? Don’t Miss Elon's Next Big Move
I believe Elon's next venture, his "Final Move," could mint more millionaires than any project he's ever been a part of before.
See More Cibus Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cibus? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cibus and other key companies, straight to your email.

About Cibus

Cibus (NASDAQ:CBUS), a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.

View Cibus Profile

More Earnings Resources from MarketBeat